IONS vs MO · rev $226.6M vs P/E 14, rev $23.28B
Ionis Pharmaceuticals Inc (IONS) versus Altria Group (MO) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Altria Group (MO) is a tobacco company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
IONS currently screens at market cap $12.28B. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Not investment advice. Open the IONS and MO stock pages for the full models.
Not investment advice.